Asian Paints
2520-7.50
Cipla
1397-15.80
Eicher Motors
7626-85.50
Nestle India
1411.2-13.80
Grasim Inds
3293.1-1.80
Hindalco Inds.
1006.5-3.20
Hind. Unilever
1964.2-10.80
ITC
264.4-1.90
Trent
2851.5-0.80
Larsen & Toubro
399413.00
M & M
3172.7-17.30
Reliance Industries
1308.3-4.80
Tata Consumer
1017.95.90
Tata Motors PVeh
3130.25
Tata Steel
182.5-1.35
Wipro
176.82-0.27
Apollo Hospitals
8696-23.00
Dr Reddy's Labs
1160.64.10
Titan Company
4957-117.00
SBI
1030.19.20
Shriram Finance
1045-2.00
Bharat Electron
409.353.60
Kotak Mah. Bank
423.1-0.40
Infosys
1128.9-11.10
Bajaj Finance
1048.2-7.70
Adani Enterp.
2903.711.90
Sun Pharma.Inds.
1921.3-10.40
JSW Steel
1298.2-7.80
HDFC Bank
708.157.35
TCS
2328.3-19.70
ICICI Bank
1440.514.00
Power Grid Corpn
268.051.25
Maruti Suzuki
1286415.00
Axis Bank
1272.518.60
HCL Technologies
1315.5-16.00
O N G C
235.6-1.90
NTPC
330.80.80
Coal India
418.60.75
Bharti Airtel
1861.4-1.40
Tech Mahindra
1596.7-26.30
Jio Financial
238.231.33
Adani Ports
1703.230.50
HDFC Life Insur.
534.551.55
SBI Life Insuran
1723.23.30
Max Healthcare
986.1-7.90
UltraTech Cem.
11340-53.00
Bajaj Auto
12032-98.00
Bajaj Finserv
1970.7-19.30
Interglobe Aviat
4978.5-41.50
Eternal
328.10.80
Max Estates Limited plans to acquire 100% ownership of nine land-owning companies in the Delhi-NCR region to expand its real estate development platform, with a potential for approximately 4-6 million square feet of development. The acquisition, valued at Rs 4.95 crore per acre of land, will be executed through a share swap, with Max Estates issuing 70,33,162 equity shares at Rs 597.50 each, totaling roughly Rs 4,202.31 crore. The sellers, including Non-Executive Chairman & Promoter Analjit Singh, Vice-Chairman & Managing Director Sahil Vachani, and related entities, are currently shareholders in the land-owning companies. The transaction, considered to be in the ordinary course of business and at arm’s length, is expected to be completed during FY27, pending shareholder approval at an Extraordinary General Meeting on September 24, 2026, and other regulatory approvals. Independent valuation reports from KPMG, Motilal Oswal, Cushman & Wakefield, and iVAS Partners support the deal.